p63 is a prostate basal cell marker and is required for prostate development.
暂无分享,去创建一个
R Montironi | M. Loda | L. Garraway | S. Signoretti | B. Isaac | F. McKeon | R. Montironi | D. Lin | D. Waltregny | M Loda | S Signoretti | J. Dilks | A. Yang | F. McKeon | D Waltregny | J Dilks | B Isaac | D Lin | L Garraway | A Yang | F McKeon | A. Yang | Beth M. Isaac | Rondolfo Montironi
[1] G van den Engh,et al. Cell-cell interaction in prostate gene regulation and cytodifferentiation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Harper,et al. Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures , 1992, The Prostate.
[3] J. Schalken,et al. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration , 1988, The Prostate.
[4] F. McKeon,et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.
[5] J. Jen,et al. A new human p53 homologue , 1998, Nature Medicine.
[6] C. Azzoli,et al. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. , 1995, Oncogene.
[7] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[8] M. Loda,et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] Rainer M. Bohle,et al. Real-time quantitative RT–PCR after laser-assisted cell picking , 1998, Nature Medicine.
[10] P. Troncoso,et al. c-met proto-oncogene expression in benign and malignant human prostate tissues. , 1995, The Journal of urology.
[11] S. J. Higgins,et al. The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.
[12] Chikashi Ishioka,et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.
[13] P. Beer-Romero,et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.
[14] Christopher T Denny,et al. Leukemia and the disruption of normal hematopoiesis , 1991, Cell.
[15] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[16] M. Loda,et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer , 2000, Oncogene.
[17] A. Collins,et al. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium , 1998, The Prostate.
[18] R. Santen,et al. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement , 1987, The Prostate.
[19] E. Bengal,et al. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene , 1998, Oncogene.
[20] D. Chopin,et al. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.
[21] R. Nagle,et al. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. , 1987, Cancer research.
[22] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[23] H. Kato,et al. A second p53-related protein, p73L, with high homology to p73. , 1998, Biochemical and biophysical research communications.
[24] G. Evans,et al. Cell proliferation studies in the rat prostate: II. The effects of castration and androgen‐induced regeneration upon basal and secretory cell proliferation , 1987, The Prostate.
[25] M. Campbell,et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.